Investors are voicing their displeasure with a Tennessee company, after it failed to get approval for one of its products to be sold in the US. Stock in Wright Medical Group took a pounding when the FDA rejected a clinical trial for its bone graft substitute.Read more ›
Post Tagged with: "Augment"
Sales and earnings are down at Memphis-based Wright Medical Group. The company is still waiting for its purchase of a Brentwood biotech firm to pay off.Read more ›